Northwest Technology Ventures

Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.

Adapx, Inc. is a software company based in Seattle, Washington, that specializes in user interface solutions designed to enhance data capture and integration for businesses and agencies. The company's primary offering, Capturx, enables users to convert natural speech, sketches, and handwriting into structured data for Microsoft Office and other backend systems. This solution helps streamline workflows by eliminating the need for data transcription and allows for efficient data collection through various mediums, including paper, touchscreens, and mobile devices. Adapx provides several tailored applications, such as Capturx for SharePoint, Capturx Forms for Excel, and Capturx for ArcGIS Desktop, among others. The company serves multiple industries, including manufacturing, defense, healthcare, and utilities. Additionally, Adapx has established strategic partnerships with major organizations like Microsoft and ESRI to enhance its product offerings. Founded in 1999, Adapx was previously known as Natural Interaction Systems.

DesignMedix, Inc. is a drug development company based in Portland, Oregon, founded in 2006. The company specializes in creating small molecule drugs aimed at combating drug resistance in infectious diseases. Its lead candidate, DM1157, offers a potential cure for drug-resistant malaria, particularly benefiting vulnerable populations such as children and pregnant women. In addition to malaria, DesignMedix is developing drug candidates targeting trichomonas vaginalis, helicobacter pylori, and various bacterial and parasitic infections. The innovative approach employed by DesignMedix involves covalently linking a chemical moiety derived from resistance reversal agents, allowing these drugs to serve dual roles as both therapeutic and resistance-modifying agents. This strategy aims to simplify treatment protocols for medical practitioners dealing with these challenging infections.

Translarity, headquartered in Silicon Valley, specializes in innovative semiconductor wafer testing solutions, focusing on advanced probe card markets. The company pioneers full-wafer testing with low cost, high performance, and short cycle times. In 2017, Translarity acquired BucklingBeam to expand its offerings, now providing a comprehensive suite of probe card solutions including full probe cards and vertical probe head solutions. Leveraging its proprietary Space Translator™ technology, Translarity addresses the rapid evolution in probe technologies. Led by an experienced management team and supported by strong financial investors, Translarity has recruited top industry talent to develop Wafer Translator™ technology, resulting in a robust IP portfolio with over 45 issued patents and more than 50 filed.

AboutUs.org is a freely editable wiki internet domain directory that lists websites along with information about their content.

Receptor BioLogix is a biotechnology company based in Palo Alto, California, focused on developing receptor-based biological therapeutics for the treatment of cancer, inflammatory, and autoimmune diseases. The company has created Hermodulins, which are pan-HER ligand traps designed to inhibit feedback mechanisms that can reduce the effectiveness of various cancer therapies. These innovations have shown anti-cancer potential in preclinical studies. Additionally, Receptor BioLogix is advancing its Intron Fusion Protein platform, which aims to discover novel splice variants of human proteins that may possess therapeutic potential.

Artielle ImmunoTherapeutics, Inc. is a biopharmaceutical company based in Tigard, Oregon, established in 2004. The company develops a platform of biologic drugs designed to address inflammatory and degenerative diseases, particularly neuro-inflammatory conditions. Artielle's focus includes multiple sclerosis, optic neuritis, methamphetamine addiction, stroke, rheumatoid arthritis, uveitis, age-related macular degeneration, and celiac disease. The company's lead compound, RTL1000, targets T-cell mediated inflammatory diseases by utilizing recombinant T-cell receptor ligands (RTLs). By blocking the action of macrophage migration inhibitory factor through its biological platform, Artielle aims to provide innovative treatments for a range of autoimmune disorders, contributing to advancements in the healthcare industry.

IP Fabrics, Inc. specializes in providing network visibility, compliance, and analytics solutions for various sectors, including telecommunications, cable, wireless, satellite, VoIP, and government agencies. The company offers a range of products designed for network surveillance and management, such as TunnelBox, which facilitates remote traffic access for diagnostics and compliance; DeepProbe, a tool for deep packet inspection and real-time alerts; and DeepSweep, which supports lawful interception and network visibility. Additionally, IP Fabrics provides CyberInsight, an analytics solution for network behavior analysis, along with intelligence modules and a software development kit to enhance its products. Founded in 2002 and based in Beaverton, Oregon, IP Fabrics serves over 50 clients, including surveillance solution providers, law enforcement, and government entities. The company also offers development services, ongoing support, and training for its systems. As of mid-2015, IP Fabrics operates as a subsidiary of Yaana Technologies, LLC.

Ambric specializes in the development and manufacturing of software-programmable interface circuits based on a massively parallel processor array architecture. The company has created a high-performance parallel processor solution that includes a structured object programming model, enabling developers to efficiently program a large number of cores. Ambric's inaugural chip architecture, the Am2045, features 336 processors on a single chip and is designed to compete with large FPGAs, DSPs, and Intel x86 processors in embedded markets. The company's products primarily target applications in video compression, medical imaging, wireless base stations, and military markets.